Literature DB >> 12507807

Pituitary apoplexy after leuprolide injection for ovum donation.

Gregory Engel1, Michelle Huston, Sachie Oshima, Carter Beck, Griffith Harsh, Myer H Rosenthal, Carlos A Camargo.   

Abstract

Patients with occult pituitary adenomas infrequently present with pituitary apoplexy. Precipitation of pituitary apoplexy by gonadotropin releasing hormone or gonadotropin releasing hormone agonists has been described. The pathophysiologic mechanism by which these agents induce apoplexy remains unclear. We describe a case of pituitary apoplexy in a young woman receiving leuprolide in preparation for ovum donation. Severe hyponatremia, cerebral vasospasm and infarction, and diabetes insipidus complicated this patient's prolonged hospital course. To our knowledge, pituitary apoplexy after gonadotropin releasing hormone agonist use for ovum donation has not been previously described. The use of leuprolide or other gonadotropin releasing hormone agonists for pituitary down-regulation in conjunction with ovarian stimulation can have serious consequences in women harboring unrecognized pituitary adenomas. Thorough endocrine screening should be performed prior to initiating therapy. Copyright Society for Adolescent Medicine, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507807     DOI: 10.1016/s1054-139x(02)00372-5

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  5 in total

Review 1.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

Authors:  Yannis Guerra; Evelyn Lacuesta; Francisco Marquez; P B Raksin; Manuel Utset; Leon Fogelfeld
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

Review 3.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

4.  Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.

Authors:  Tsung-Yi Huang; Jih-Pin Lin; Ann-Shung Lieu; Yi-Ting Chen; Hung-Sheng Chen; Mei-Yu Jang; Jung-Tsung Shen; Wen-Jeng Wu; Shu-Pin Huang; Yung-Shun Juan
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

5.  Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.

Authors:  Vanessa Triviño; Olga Fidalgo; Antía Juane; Jorge Pombo; Fernando Cordido
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.